SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 and Rule 13a-17
or 15d-17 Thereunder
RCM TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
2500 McClellan Avenue
3rd Floor, Kevon Office Center
Pennsauken, New Jersey 08109
(Address of Principal Executive Offices (Zip Code)
Issuer's telephone number, including area code (609) 486-1777
--------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number
of shares outstanding:
1. Title of Security Common Stock, par value $.05 per share
2. Number of shares outstanding before the change 14,713,565
3. Number of shares outstanding after the change 16,275,118
4. Effective date of change August 30, 1995
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution,
stock split, reverse split, acquisition of stock for treasury, etc.)
Issuance of shares of Common Stock in connection with the acquisition
of the shares of Cataract, Inc. by the Issuer's subsidiary CI
Acquisition Corp.
Give a brief description of transaction:CI Acquisition Corp. merged with
Cataract, Inc. on August 30, 1995. The acquisition price included the
issuance of 1,561,553 shares of Common Stock to the shareholders of
Cataract. The shares have not been registered under the Securities Act of
1933.
<PAGE>
II. CHANGE IN NAME OF ISSUER
1. Name prior to Change N/A
2. Name after Change N/A
3. Effective date of charter amendment changing name N/A
4. Date of shareholder approval of change, if required N/A
RCM TECHNOLOGIES, INC.
DATE: September 1, 1995 BY:
(Officer's Signature & Title)
Stanton Remer,
Chief Financial Officer
